These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 15328094

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.
    Idelevich EA, Kriegeskorte A, Stubbings W, Kahl BC, Peters G, Becker K.
    J Antimicrob Chemother; 2011 Dec; 66(12):2809-13. PubMed ID: 21948963
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ, Castanheira M, Mendes RE, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [Abstract] [Full Text] [Related]

  • 24. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.
    Pfaller MA, Beach ML, Gordon KA, Jones RN.
    J Chemother; 2002 Feb; 14(1):13-8. PubMed ID: 11892893
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
    Bogdanovich T, Smith KA, Clark C, Pankuch GA, Lin G, McGhee P, Dewasse B, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2323-9. PubMed ID: 16801408
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
    Metzler K, Hansen GM, Hedlin P, Harding E, Drlica K, Blondeau JM.
    Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.
    Allen GP, Kaatz GW, Rybak MJ.
    Int J Antimicrob Agents; 2004 Aug; 24(2):150-60. PubMed ID: 15288314
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS, Wymbs RA, Vellozzi EM, Udell IJ.
    Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
    [Abstract] [Full Text] [Related]

  • 39. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M, Joseph J, Khande H, Bhagwat S, Patel M.
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.
    Castanheira M, Deshpande LM, Jones RN, Farrell DJ.
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):263-6. PubMed ID: 22321998
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.